Cortice Biosciences, Inc. 4
4 · CNS Pharmaceuticals, Inc. · Filed Aug 6, 2024
Insider Transaction Report
Form 4
Cortice Biosciences, Inc.
10% Owner
Holdings
- 573,368
Common Stock
Footnotes (1)
- [F1]This Form 4 is being filed to report the termination of the Reporting Person's status as a section 16 reporting person as a result of an increase in the number of shares of Common Stock outstanding.